Friday, July 10, 2026

pharma · Multiple Myeloma · Neoplasms

Teva/Actavis Generics

Teva/Actavis Generics trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Salt Lake City, USA HQ
1992 Founded
100 Employees
EMA registrant Type
Company details
Status
Public
HQ
Salt Lake City, USA
Founded
1992
Employees
100
Programs
4
Drugs
1
Patents
0
Intelligence · Clinical Trials

Teva/Actavis Generics clinical trials

Registry index of 4 ClinicalTrials.gov studies linked to Teva/Actavis Generics programs — each row shows trial ID, program name, phase, status, and indication.

Teva/Actavis Generics trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

4 updates

Latest clinical program signals indexed for Teva/Actavis Generics.

  1. Reslizumab — Phase 3

    Clinical update
  2. TEV-56248 — Phase 3

    Clinical update
  3. CEP-18770 — Phase 2

    Clinical update
  4. Modakafusp Alfa — Phase 2

    Clinical update

Trial registry

4 studies